Atıf İçin Kopyala
Küp A., Çelik M., Uslu A., Külahçıoğlu Ş., Tükenmez Tigen E., Demir S., ...Daha Fazla
Troia Medical Journal, cilt.3, sa.3, ss.96-99, 2022 (Hakemli Dergi)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
3
Sayı:
3
-
Basım Tarihi:
2022
-
Doi Numarası:
10.55665/troiamedj.1151301
-
Dergi Adı:
Troia Medical Journal
-
Derginin Tarandığı İndeksler:
Asos İndeks
-
Sayfa Sayıları:
ss.96-99
-
Marmara Üniversitesi Adresli:
Evet
Özet
Objective: Electrocardiographic alterations were investigated following the second dosage of COVID-19 mRNA vaccination. Methods: A total of 260 individuals after two doses of COVID-19 vaccine with Pfizer-BioNTech were included in the study. The electrocardiographic parameters recorded at baseline and approximately one week later after two doses of Pfizer-BioNTech vaccine were compared for all patients. Results: PR interval was increased and QTc maximum interval was decreased significantly after second dose COVID-19 mRNA vaccination. Baseline and post-second dose vaccination states regarding P wave dispersion and QT dispersion/Tp-e interval which have been recognized to imply inhomogeneous atrial conduction and heterogeneity in ventricular repolarization were similar between groups. Conclusion: Our findings suggest that there should be no concern related to asymptomatic involvement of the myocardium subsequent the second dose of COVID-19 mRNA vaccination.